Skip Navigation

European Heart Journal 2000 21(4):335-336; doi:10.1053/euhj.1999.1915
Copyright © 2000 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Petkun, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Petkun, W.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Letter to the Editor

AT1-receptor blockers

W. Petkun, Medical Director

Bristol-Myers Squibb Company

References

  1. Pitt B, Poole-Wilson P, Segal R. Effects of losartan versus captopril on mortality in patients with symptomatic heart failure: rationale, design, and baseline characteristics of patients in the losartan heart failure survival study—ELITE II. J Cardiac Failure. 1999;5:146–154[CrossRef][Web of Science][Medline]
  2. Kassler-Taub K, Littlejohn T, Elliott W. Comparative efficacy of two angiotensin II receptor antagonists, irbesartan and losartan, in mildto-moderate hypertension. Am J Hypertens. 1998;11:445–453[CrossRef][Web of Science][Medline]
  3. Oparil S, Guthrie R, Lewin AJ. An elective-titration study of the comparative effectiveness of two angiotensin II-receptor blockers, irbesartan and losartan. Clin Therapeut. 1998;20:398–409[CrossRef][Web of Science][Medline]
  4. Andersson OK, Neldam S. The antihypertensive effect and tolerability of candesartan cilexetil, a new generation angiotensin II antagonist, in comparison with losartan. Blood Pressure. 1998;7:53–59[CrossRef][Medline]
  5. Mazzolai L, Maillard M, Rossat J. Angiotensin II receptor blockade in normotensive subjects: a direct comparison of three AT1receptor antagonists. Hypertens. 1999;33:850–855[Abstract/Free Full Text]
  6. Belz GG, Butzer R, Kober S. Greater extent and duration of antagonism of irbesartan on angiotensin II pressor response and radioligand binding in man compared to losartan and valsartan. J Am Coll Cardiol. 1999;33:284A

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Petkun, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Petkun, W.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?